HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plethico’s Natrol Acquisition Reflects Growing Indian Supplement Investment

This article was originally published in The Tan Sheet

Executive Summary

Plethico Pharmaceuticals' $80.8 million acquisition of Natrol could be a bellwether of Indian firms' interest in growing their presence in the U.S. supplement market

You may also be interested in...



Supplement Start-Up Revo Biolabs Has Holistic Health, Global Growth In Mind

Dietary supplement industry veteran Elliott Balbert returns from semi-retirement to head Revo Biolabs, a company focused on the U.S. market with plans for segment and geographic expansion.

Sanofi-Aventis Nurtures Supplement Interest With Symbion Consumer Buy

The dietary supplement market's attraction to pharmaceutical firms surfaces again with Sanofi-Aventis acquiring Australia's leading vitamin and mineral supplements company, Primary Health Care's Symbion Consumer business

Experts, FDAer Address Issues Set Ablaze By Melamine Contamination

Legitimate businesses need to think like the people adulterating products in order to anticipate scenarios that would lead to another unknown contaminant like melamine entering the food supply, experts agree

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS137835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel